EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
41 hedge funds and large institutions have $180M invested in Evelo Biosciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
23% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 13
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Holders
41
Holding in Top 10
1
Calls
$207K
Puts
$30K
Top Buyers
| 1 | +$3.89M | |
| 2 | +$615K | |
| 3 | +$501K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$220K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$48.3K |
Top Sellers
| 1 | -$755K | |
| 2 | -$716K | |
| 3 | -$621K | |
| 4 |
E
Ergoteles
New York
|
-$576K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$423K |